Objective: Genetic polymorphisms in ALDH2 and C12orf30 genes have been reported to increase the risk of developing esophageal squamous cell carcinoma (ESCC). This study aims to investigate the relationship between ALDH2 rs671 and c12orf30 rs4767364 polymorphisms in the chromosome 12q24 gene, and risk and prognosis of individuals developing esophageal cancer (ESCC) in Xinjiang Kazak and Han populations.
only a small portion of people exposed to the aforementioned risk factors will go on to develop ESCC. In addition, studies of familial aggregation and its significant to EC have also been reported, highlighting a genetic contribution to the pathogenesis of ESCC. 4 Interestingly, multiple gene polymorphisms, such as oncogene activation coupled with the loss of tumor suppressor genes, are reported to affect the progression and prognosis of ESCC. 5, 6 The Aldehyde dehydrogenase-2 (ALDH2) gene is composed of 12 coding exons that are located on chromosome 12q24. 7 It has been shown that the varied ALDH2 rs671 gene in different Asian populations may contribute to the susceptibility to ESCC. 8 The A allele at the ALDH2 rs671 gene locus has been linked with an increase in susceptibility in developing ESCC in Chinese populations, implying that abnormally high levels of acetaldehyde may be an indicator for ESCC development. 9 Another gene of particular interest is the cl2orf30 gene.
The c12orf30 gene is also located on chromosome 12q24 and is found to play a role in the type 1 diabetes due to their presumed significance in immune signaling. 10 Furthermore, a study has shown that variants in c12orf30 regions are associated with autoimmune diseases such as rheumatoid arthritis as well as systemic lupus erythematosus.
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More importantly to us, c12orf30 rs4767364 is identified to be related to upper aero-digestive tract cancers including ESCC. 12 Thus, we conduct this study in order to gain a better understanding between the associations of ALDH2 rs671 and c12orf30 rs4767364
polymorphisms with the risk and prognosis of ESCC in Xinjiang Han and Kazakh populations in China.
| MATERIALS AND METHODS

| Ethics statement
This study was approved by the Ethical Committee of the First Affiliated Hospital of Xinjiang Medical University. Written informed consents were obtained from all study subjects. personal information and clinical data of smoking, drinking, and family history of each subject was obtained by questioning the subjects and their family members.
| Subject selection
| Sample preparation and single nucleotide polymorphism (SNP) detection
Participants were first subjected to 5 mL of venous blood collection which were anticoagulated with ethylene diamine tetraacetic acid (EDTA) and then stored at −80°C for preservation. The extraction of DNA was carried out using a genomic DNA blood extraction kit (TianGen Biotech Co., Ltd, Beijing, China). TaqMan probes were applied to detect the genotypes of targeted gene polymorphism.
The SNPs of ALDH2 rs671 and c12orf30 rs4767364 were synthe- 
| Follow up
Follow-up procedures including; outpatient appointments, telephone calls and letters were employed on all 127 cases of the case group patients to keep track of their condition. The follow-up procedure was conducted every six months from the date of our grouping to April 1st, 2015. The Survival time of each patient was calculated from the first day after the operation until the date of death or until the end of the followup procedure period. The survival time was calculated by month, and the follow-up duration was five years. In 127 patients in the case group, there were 10 lost cases, with a loss rate of 8%, among which there were two deaths in the first year and eight deaths in the second year.
| Statistical analysis
Statistical package for the social sciences (SPSS) software 18.0 (SPSS Inc., Chicago, IL, USA) was applied to carry out statistical analysis for this investigation. The Measurement data were expressed as mean±standard deviation. A t test was used to statistically compare the age distribution between the two study groups, and χ 2 was employed to compare the allelic and genotype frequencies between the two groups. The relative risk was calculated by an odds ratio (OR) with 95% confidence interval (95% CI). Moreover, Hardy-Weinberg was performed to find out whether the population was well represented by our samples, and a Kaplan-Meier estimator was used to along with Log-Rank to estimate the survival function and thus used to draw the survival curves of patients for the two parameters that we are investigating The Cox regression analysis was applied to calculate the hazard ratios (HR) with 95% CI. All tests were two-sided probability test, and P values of <.05 were considered as statistically significant.
| RESULTS
| Comparisons of baseline characteristics between ESCC patients and healthy controls in the Kazak and Han populations
There was no significance in the gender, age, numbers of smokers and drinkers between the case and control groups (all P>.05) ( Table 1 ).
| Distribution of ALDH2 rs671 and c12orf30 rs4767364 genotypes in Kazak and Han populations conformed to the Hardy-Weinberg balance
As shown in Table 2 , the distribution of ALDH2 rs671 and c12orf30
rs4767364 genotypes in Kazak and Han populations conformed to
Hardy-Weinberg balance, suggesting that the frequency of ALDH2 rs671 genotypes and c12orf30 rs4767364 genotypes in the subjects was in equilibrium and showed group representation. 
| Genotype frequencies of ALDH2 rs671 (G>A) and C12orf30 rs4767364 (A>G) polymorphisms in ESCC patients and healthy controls in the Kazak and Han populations
| Correlations of ALDH2 rs671 (G>A) and C12orf30 rs4767364 (A>G) polymorphisms with the prognosis of patients with ESCC in the Kazak and Han population
In the 65 Kazak patients, Cox regression analysis indicated that the ALDH2 rs671 (G>A) polymorphism was related to poor prognosis of EC (P=.009). The mutant genotype (GA+AA) carriers demonstrated higher death risks (HR=4.524; 95% CI=1.441-14.210) in comparison homozygous carriers of GG genotype. Furthermore, the c12orf30 rs4767364 (A>G) polymorphism was also associated with poor prognosis of EC (P=.001), and the risk of death was significantly higher in AG+GG carriers (HR=9.538; 95%
CI=2.302-39.530) than the AA carriers (Table 5 ). According to the Kaplan-Meier method, the 1-, 3-and 5-year survival rates of Kazak patients were 94.41%, 74.75% and 57.31%, respectively.
The Kaplan-Meier survival curves shows that rs671 and rs4767364
polymorphisms were positively correlated with poor prognosis in the Kazak EC patients (rs671: Log rank P=.002 and rs4767364: Log rank P=.001) ( Figure 1A ,B).
In the 62 Han patients, Cox regression analysis exhibited that the prognosis of EC was affected by ALDH2 rs671 (G>A)
T A B L E 3 Relationship between 12q24 gene polymorphisms (rs671 and rs4767364) and the susceptibility to ESCC between the case and control groups (total Han and Kazak populations) Figure 1C ).
Meanwhile, the rs4767364 position failed to demonstrate an association with poor prognosis of ESCC, as well as the survival time of AA carriers and AG+GG carriers, which were not significantly different (Log rank P=.372) ( Figure 1D ).
| DISCUSSION
Over the recent years, increased gene polymorphisms have been discovered to be involved in the risk and prognosis of ESCC as more and more gene variants are identified to be potential prognostic markers in ESCC patients. 14, 15 Our study aims to elucidate the effects of ALDH2 and c12orf30 gene polymorphisms on the chromosome 12q24 region in determining the risk and prognosis of ESCC. Our findings demonstrated that the ALDH2 rs671 (G>A) polymorphism is associated with increased susceptibility to ESCC in Kazak and Han population.
The other gene polymorphism and c12orf30 rs4767364 (A>G) is also linked with ESCC and allows us to determine patient prognosis in the Kazak population.
We showed that the frequency of GA and AA genotypes (40.00% and 13.85%) at ALDH2 rs671 in the Kazak ESCC patients was significantly higher than those in the control group (26.67% and 5.33%).
The susceptibility toward ESCC is also higher in the AA and GA carriers compared to the GG carriers. However, the frequencies of GG, GA, and AA at ALDH2 rs671 showed no statistical significance in
Han patients. To the best of our knowledge, the frequency of A allele (GA+AA) carriers at the rs671 is remarkably higher in coronary artery disease (CAD) patients than the healthy controls, implying that the ALDH2 rs671 polymorphism is related to an increased risk of CAD in Han Chinese. 16 Wu et al. reported that the A allele at rs671 is identified have an increase in susceptibility toward ESCC among moderate to heavy drinkers in the Chinese population, suggesting the high levels of acetaldehyde may contribute to the development of ESCC. Additionally, Li et al. 17 also demonstrated that the ALDH2 A allele carriers who are also heavy drinkers are prominently associated with the increased risk of developing ESCC. Interestingly, a study by Ding et al. 18 shows that the frequency of ALDH2 GA and AA genotypes in the ESCC patients were also higher than the controls, and they also demonstrate that the ALDH2 A/A carriers show increased susceptibility to ESCC than G/A carriers in Southeastern Chinese males, which is largely consistent with our results. Moreover, previous study has also
shown that regions around Taihang Mountain, such as Henan, Hebei, Shanxi, and north Xinjiang, which is in the north and west of China, there were significantly elevated mortality rates of ESCC. 19 In addition, Cox regression analysis in our study shows that ALDH2 rs671 positivity was found significantly related to lymph node metastasis in patients with gastric cancer. 22 More importantly, Li et al. 23 showed that ALDH2 expression is higher in breast cancer patients with lymph node metastasis compared with those without, suggesting ALDH2 may be a potent indicator of tumor invasion and metastasis. On the basis of our findings, we can say that the ALDH2 rs671 polymorphism may affect ALDH2 expression and thus have positive correlation with the poor prognosis of ESCC.
Our study also concluded that the frequency of AA, AG, and GG populations. This result might support our findings that c12orf30 rs4767364 (A>G) is related to poor prognosis of ESCC in Kazak patients.
In conclusion, the ALDH2 rs671 (G>A) polymorphism at the 
